Neuroimaging of children following prenatal drug exposure

Seminars in Cell and Developmental Biology

Volumn 20, Issue 4, 2009, Pages 441-454

  Derauf, Chris ^a   Kekatpure, Minal ^b   Neyzi, Nurunisa ^b   Lester, Barry ^c   Kosofsky, Barry ^b  

^a UNIVERSITY OF HAWAII   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

Behavioral teratology; Drugs of abuse; MRI; Neuroimaging; Prenatal drug exposure

Indexed keywords

ALCOHOL; CANNABIS; COCAINE; METHAMPHETAMINE;

BASAL GANGLION; BRAIN INJURY; BRAIN MALFORMATION; FRONTAL CORTEX; HUMAN; NEUROIMAGING; NEUROTOXICITY; PRENATAL DRUG EXPOSURE; REVIEW; TOBACCO;

CANNABIS SATIVA; NICOTIANA TABACUM;

EID: 67549124826     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcdb.2009.03.001     Document Type: Review

References (203)

1. Lewis M.B.M. Mothers, babies, and cocaine: The role of toxins in development (1995), Erlbaum, Hillsdale, NJ
2. Lester B.M., LaGasse L.L., and Seifer R. Cocaine exposure and children: the meaning of subtle effects. Science 282 October (5389) (1998) 633-634
3. Levitt P., Harvey J.A., Friedman E., Simansky K., and Murphy E.H. New evidence for neurotransmitter influences on brain development. Trends Neurosci 20 June (6) (1997) 269-274
4. Mayes L.C. Developing brain and in utero cocaine exposure: effects on neural ontogeny. Dev Psychopathol 11 4 (1999) 685-714
5. Malanga III C.J., and Kosofsky B.E. Mechanisms of action of drugs of abuse on the developing fetal brain. Clin Perinatol 26 March (1) (1999) 17-37 v-vi
6. Meier E.H.L., and Schousboe A. Neurotransmitters as developmental signals. Neurochem Int 19 1-2 (1991) 1-15
7. Harvey J.A. Cocaine effects on the developing brain: current status. Neurosci Biobehav Rev 27 January (8) (2004) 751-764
8. Gressens P., Kosofsky B.E., and Evrard P. Cocaine-induced disturbances of corticogenesis in the developing murine brain. Neurosci Lett 140 June (1) (1992) 113-116
9. Kosofsky B.E., Wilkins A.S., Gressens P., and Evrard P. Transplacental cocaine exposure: a mouse model demonstrating neuroanatomic and behavioral abnormalities. J Child Neurol 9 July (3) (1994) 234-241
10. Lidow M.S., and Song Z.M. Primates exposed to cocaine in utero display reduced density and number of cerebral cortical neurons. J Comp Neurol 435 July (3) (2001) 263-275
11. Harvey J.A., Romano A.G., Gabriel M., et al. Effects of prenatal exposure to cocaine on the developing brain: anatomical, chemical, physiological and behavioral consequences. Neurotox Res 3 January (1) (2001) 117-143
12. Crandall J.E., Hackett H.E., Tobet S.A., Kosofsky B.E., and Bhide P.G. Cocaine exposure decreases GABA neuron migration from the ganglionic eminence to the cerebral cortex in embryonic mice. Cereb Cortex 14 June (6) (2004) 665-675
13. Guerriero R.M., Rajadhyaksha A., Crozatier C., Giros B., Nosten-Bertrand M., and Kosofsky B.E. Augmented constitutive CREB expression in the nucleus accumbens and striatum may contribute to the altered behavioral response to cocaine of adult mice exposed to cocaine in utero. Dev Neurosci 27 March-August (2-4) (2005) 235-248
14. Steiner H., and Gerfen C.R. Dynorphin regulates D1 dopamine receptor-mediated responses in the striatum: relative contributions of pre- and postsynaptic mechanisms in dorsal and ventral striatum demonstrated by altered immediate-early gene induction. J Comp Neurol 376 December (4) (1996) 530-541
15. Bhat R.V., and Baraban J.M. Activation of transcription factor genes in striatum by cocaine: role of both serotonin and dopamine systems. J Pharmacol Exp Ther 267 October (1) (1993) 496-505
16. Novikova S.I., He F., Bai J., Badan I., Lidow I.A., and Lidow M.S. Cocaine-induced changes in the expression of apoptosis-related genes in the fetal mouse cerebral wall. Neurotoxicol Teratol 27 January-February (1) (2005) 3-14
17. Jensen A., Hohmann M., and Kunzel W. Redistribution of fetal circulation during repeated asphyxia in sheep: effects on skin blood flow, transcutaneous PO2, and plasma catecholamines. J Dev Physiol 9 February (1) (1987) 41-55
18. Lipton J.W., Vu T.Q., Ling Z., Gyawali S., Mayer J.R., and Carvey P.M. Prenatal cocaine exposure induces an attenuation of uterine blood flow in the rat. Neurotoxicol Teratol 24 March-April (2) (2002) 143-148
19. Bassett J.M., and Hanson C. Catecholamines inhibit growth in fetal sheep in the absence of hypoxemia. Am J Physiol 274 June (6 Pt 2) (1998) R1536-R1545
20. Woods Jr. J.R., Plessinger M.A., and Clark K.E. Effect of cocaine on uterine blood flow and fetal oxygenation. JAMA 257 February (7) (1987) 957-961
21. Koegler S.M., Seidler F.J., Spencer J.R., and Slotkin T.A. Ischemia contributes to adverse effects of cocaine on brain development: suppression of ornithine decarboxylase activity in neonatal rat. Brain Res Bull 27 December (6) (1991) 829-834
22. Wilkins A.S., Marota J.J., Tabit E., and Kosofsky B.E. Transplacental cocaine exposure. 3: Mechanisms underlying altered brain development. Neurotoxicol Teratol 20 May-June (3) (1998) 239-249
23. Lester B, Padbury, JF. The third pathophysiology of prenatal cocaine exposure. Dev Neurosci, in press.
24. Shankaran S., Lester B.M., Das A., et al. Impact of maternal substance use during pregnancy on childhood outcome. Semin Fetal Neonatal Med 12 April (2) (2007) 143-150
25. Frank D.A., Augustyn M., Knight W.G., Pell T., and Zuckerman B. Growth, development, and behavior in early childhood following prenatal cocaine exposure: a systematic review. JAMA 285 March (12) (2001) 1613-1625
26. Heier L.A., Carpanzano C.R., Mast J., Brill P.W., Winchester P., and Deck M.D. Maternal cocaine abuse: the spectrum of radiologic abnormalities in the neonatal CNS. AJNR Am J Neuroradiol 12 September-October (5) (1991) 951-956
27. Gomez-Anson B., and Ramsey R.G. Pachygyria in a neonate with prenatal cocaine exposure: MR features. J Comput Assist Tomogr 18 July-August (4) (1994) 637-639
28. Gieron-Korthals M.A., Helal A., and Martinez C.R. Expanding spectrum of cocaine induced central nervous system malformations. Brain Dev 16 May-June (3) (1994) 253-256
29. Dixon S.D., and Bejar R. Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates. J Pediatr 115 November (5 Pt 1) (1989) 770-778
30. Kliegman R.M., Madura D., Kiwi R., Eisenberg I., and Yamashita T. Relation of maternal cocaine use to the risks of prematurity and low birth weight. J Pediatr 124 May (5 Pt 1) (1994) 751-756
31. Cohen H.L., Sloves J.H., Laungani S., Glass L., and DeMarinis P. Neurosonographic findings in full-term infants born to maternal cocaine abusers: visualization of subependymal and periventricular cysts. J Clin Ultrasound 22 June (5) (1994) 327-333
32. Dow-Edwards D.L., Benveniste H., Behnke M., et al. Neuroimaging of prenatal drug exposure. Neurotoxicol Teratol 28 May-June (3) (2006) 386-402
33. Avants B.B., Hurt H., Giannetta J.M., et al. Effects of heavy in utero cocaine exposure on adolescent caudate morphology. Pediatr Neurol 37 October (4) (2007) 275-279
34. Neyzi N., Quinn B.T., Kekatpur M., et al. Segmentation of Brain structures in a pediatric population with prenatal cocaine exposure. Paper Presented at: Society for Neuroscience Conference. San Diego (2007)
35. Rivkin M.J., Davis P.E., Lemaster J.L., et al. Volumetric MRI study of brain in children with intrauterine exposure to cocaine, alcohol, tobacco, and marijuana. Pediatrics 121 April (4) (2008) 741-750
36. Gabriel M., and Taylor C. Prenatal exposure to cocaine impairs neuronal coding of attention and discriminative learning. Ann N Y Acad Sci 846 June (1998) 194-212
37. Warner T.D., Behnke M., Eyler F.D., et al. Diffusion tensor imaging of frontal white matter and executive functioning in cocaine-exposed children. Pediatrics 118 November (5) (2006) 2014-2024
38. Smith L.M., Chang L., Yonekura M.L., et al. Brain proton magnetic resonance spectroscopy and imaging in children exposed to cocaine in utero. Pediatrics 107 February (2) (2001) 227-231
39. Smith L.M., Qureshi N., Renslo R., and Sinow R.M. Prenatal cocaine exposure and cranial sonographic findings in preterm infants. J Clin Ultrasound 29 February (2) (2001) 72-77
40. Volpe J.J. Effect of cocaine use on the fetus. N Engl J Med 327 August (6) (1992) 399-407
41. Rao H., Wang J., Giannetta J., et al. Altered resting cerebral blood flow in adolescents with in utero cocaine exposure revealed by perfusion functional MRI. Pediatrics 120 November (5) (2007) e1245-e1254
42. Hurt H., Giannetta J.M., Korczykowski M., et al. Functional magnetic resonance imaging and working memory in adolescents with gestational cocaine exposure. J Pediatr 152 March (3) (2008) 371-377
43. Sheinkopf SJ, Lester BM, Sanes JN, Eliassen JC, Hutchison E, Seifer R, LaGasse L, Durston S, Casey BJ. Functional MRI and response inhibition in children exposed to cocaine in utero: Preliminary findings. Dev Neurosci, in press.
44. Greenblatt JC, Gfroerer JC. Methamphetamine abuse in the United States. Rockville, MD: U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration (SAMHSA), Office of Applied Studies. Last accessed 5/23/08 at: http://www.oas.samhsa.gov/NHSDA/Treatan/treana13.htm; 1996.
45. Johnston LD OMP, Bahman JG, Schulenberg JE. Monitoring the future national survey results on drug use, 1975-2004. Vol. I: secondary school students. Bethesda M, National Institute on Drug Abuse; 2005a.
46. Johnston LD OMP, Bahman JG, Schulenberg JE. Monitoring the future national survey results on drug use, 1975-2004. Vol. II: college students and adults ages 19-45. Bethesda M, National Institute on Drug Abuse; 2005b.
47. Anglin M.D.B.C., Perrochet B., Stamper E., and Dawud-Noursi S. History of the methamphetamine problem. J Psychoactive Drugs 32 2 (2000) 137-141
48. Ho E., Karimi-Tabesh L., and Koren G. Characteristics of pregnant women who use ecstasy (3,4-methylenedioxymethamphetamine). Neurotoxicol Teratol 23 November-December (6) (2001) 561-567
49. Derauf C.K.A., Frank D.A., Grandinetti A., and Easa D. The prevalence of methamphetamine and other drug use during pregnancy in Hawaii. J Drug Issues 3 4 (2003) 1001-1016
50. Arria A.M., Derauf C., Lagasse L.L., et al. Methamphetamine and other substance use during pregnancy: preliminary estimates from the Infant Development, Environment, and Lifestyle (IDEAL) study. Matern Child Health J 10 May (3) (2006) 293-302
51. Skelton M.R., Williams M.T., and Vorhees C.V. Developmental effects of 3, 4-methylenedioxymethamphetamine: a review. Behav Pharmacol 19 March (2) (2008) 91-111
52. McCann U.D., and Ricaurte G.A. Amphetamine neurotoxicity: accomplishments and remaining challenges. Neurosci Biobehav Rev 27 January (8) (2004) 821-826
53. Frost D.O., and Cadet J.L. Effects of methamphetamine-induced neurotoxicity on the development of neural circuitry: a hypothesis. Brain Res Brain Res Rev 34 December (3) (2000) 103-118
54. Quinton M.S., and Yamamoto B.K. Causes and consequences of methamphetamine and MDMA toxicity. Aaps J 8 2 (2006) E337-347
55. Weissman A.D., and Caldecott-Hazard S. Developmental neurotoxicity to methamphetamines. Clin Exp Pharmacol Physiol 22 May (5) (1995) 372-374
56. Jeng W., Wong A.W., Ting A.K.R., and Wells P.G. Methamphetamine-enhanced embryonic oxidative DNA damage and neurodevelopmental deficits. Free Radic Biol Med 39 August (3) (2005) 317-326
57. Robinson T.E., and Kolb B. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci 17 November (21) (1997) 8491-8497
58. Sekine Y., Minabe Y., Ouchi Y., et al. Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. Am J Psychiatry 160 September (9) (2003) 1699-1701
59. Paulus M.P., Hozack N.E., Zauscher B.E., et al. Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects. Neuropsychopharmacology 26 January (1) (2002) 53-63
60. Volkow N.D., Chang L., Wang G.J., et al. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 158 March (3) (2001) 377-382
61. Thompson P.M., Hayashi K.M., Simon S.L., et al. Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 24 June (26) (2004) 6028-6036
62. Iwazaki T., McGregor I.S., and Matsumoto I. Protein expression profile in the amygdala of rats with methamphetamine-induced behavioral sensitization. Neurosci Lett 435 April (2) (2008) 113-119
63. Stanwood G.D., and Levitt P. Drug exposure early in life: functional repercussions of changing neuropharmacology during sensitive periods of brain development. Curr Opin Pharmacol 4 February (1) (2004) 65-71
64. Lewis B.A., Singer L.T., Short E.J., et al. Four-year language outcomes of children exposed to cocaine in utero. Neurotoxicol Teratol 26 September-October (5) (2004) 617-627
65. Seifer R., LaGasse L.L., Lester B., et al. Attachment status in children prenatally exposed to cocaine and other substances. Child Dev 75 May-June (3) (2004) 850-868
66. Bandstra E.S., Morrow C.E., Anthony J.C., Accornero V.H., and Fried P.A. Longitudinal investigation of task persistence and sustained attention in children with prenatal cocaine exposure. Neurotoxicol Teratol 23 November-December (6) (2001) 545-559
67. Mundy P. Annotation: the neural basis of social impairments in autism: the role of the dorsal medial-frontal cortex and anterior cingulate system. J Child Psychol Psychiatry 44 September (6) (2003) 793-809
68. Burchfield D.J., Lucas V.W., Abrams R.M., Miller R.L., and DeVane C.L. Disposition and pharmacodynamics of methamphetamine in pregnant sheep. JAMA 265 April (15) (1991) 1968-1973
69. Stek A.M., Fisher B.K., Baker R.S., Lang U., Tseng C.Y., and Clark K.E. Maternal and fetal cardiovascular responses to methamphetamine in the pregnant sheep. Am J Obstet Gynecol 169 October (4) (1993) 888-897
70. Stek A.M., Baker R.S., Fisher B.K., Lang U., and Clark K.E. Fetal responses to maternal and fetal methamphetamine administration in sheep. Am J Obstet Gynecol 173 November (5) (1995) 1592-1598
71. Vicentic A., Jones D.C., and The CART. (cocaine- and amphetamine-regulated transcript) system in appetite and drug addiction. J Pharmacol Exp Ther 320 February (2) (2007) 499-506
72. Guerrini I., Thomson A.D., and Gurling H.D. The importance of alcohol misuse, malnutrition and genetic susceptibility on brain growth and plasticity. Neurosci Biobehav Rev 31 2 (2007) 212-220
73. Sizonenko S.V., Borradori-Tolsa C., Bauthay D.M., Lodygensky G., Lazeyras F., and Huppi P. Impact of intrauterine growth restriction and glucocorticoids on brain development: insights using advanced magnetic resonance imaging. Mol Cell Endocrinol 254-255 July (2006) 163-171
74. Eriksson M., Larsson G., Winbladh B., and Zetterstrom R. The influence of amphetamine addiction on pregnancy and the newborn infant. Acta Paediatr Scand 67 January (1) (1978) 95-99
75. Billing L., Eriksson M., Larsson G., and Zetterstrom R. Amphetamine addiction and pregnancy. III. One year follow-up of the children. Psychosocial and pediatric aspects. Acta Paediatr Scand 69 September (5) (1980) 675-680
76. Eriksson M., Larsson G., and Zetterstrom R. Amphetamine addiction and pregnancy. II. Pregnancy, delivery and the neonatal period. Socio-medical aspects. Acta Obstet Gynecol Scand 60 3 (1981) 253-259
77. Eriksson M., Billing L., Steneroth G., and Zetterstrom R. Pre-school children of amphetamine-addicted mothers. II. Environment and supportive social welfare. Acta Paediatr Scand 74 March (2) (1985) 185-190
78. Eriksson M., Billing L., Steneroth G., and Zetterstrom R. Health and development of 8-year-old children whose mothers abused amphetamine during pregnancy. Acta Paediatr Scand 78 November (6) (1989) 944-949
79. Eriksson M., Jonsson B., Steneroth G., and Zetterstrom R. Cross-sectional growth of children whose mothers abused amphetamines during pregnancy. Acta Paediatr 83 June (6) (1994) 612-617
80. Eriksson M., and Zetterstrom R. Amphetamine addiction during pregnancy: 10-year follow-up. Acta Paediatr Suppl 404 November (1994) 27-31
81. Cernerud L., Eriksson M., Jonsson B., Steneroth G., and Zetterstrom R. Amphetamine addiction during pregnancy: 14-year follow-up of growth and school performance. Acta Paediatr 85 February (2) (1996) 204-208
82. Eriksson M., Jonsson B., Steneroth G., and Zetterstrom R. Amphetamine abuse during pregnancy: environmental factors and outcome after 14-15 years. Scand J Public Health 28 June (2) (2000) 154-157
83. Smith L.M., Lagasse L.L., Derauf C., et al. Prenatal methamphetamine use and neonatal neurobehavioral outcome. Neurotoxicol Teratol 30 January-February (1) (2008) 20-28
84. Smith L.M., LaGasse L.L., Derauf C., et al. The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics 118 September (3) (2006) 1149-1156
85. Smith L.M., Chang L., Yonekura M.L., Grob C., Osborn D., and Ernst T. Brain proton magnetic resonance spectroscopy in children exposed to methamphetamine in utero. Neurology 57 July (2) (2001) 255-260
86. Kreis R., Ernst T., and Ross B.D. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 30 October (4) (1993) 424-437
87. Toft P.B., Christiansen P., Pryds O., Lou H.C., and Henriksen O. T1, T2, and concentrations of brain metabolites in neonates and adolescents estimated with H-1 MR spectroscopy. J Magn Reson Imaging 4 January-February (1) (1994) 1-5
88. Toft P.B., Leth H., Lou H.C., Pryds O., and Henriksen O. Metabolite concentrations in the developing brain estimated with proton MR spectroscopy. J Magn Reson Imaging 4 September-October (5) (1994) 674-680
89. Kreis R., Hofmann L., Kuhlmann B., Boesch C., Bossi E., and Huppi P.S. Brain metabolite composition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 48 December (6) (2002) 949-958
90. Filippi C.G., Ulug A.M., Deck M.D., Zimmerman R.D., and Heier L.A. Developmental delay in children: assessment with proton MR spectroscopy. AJNR Am J Neuroradiol 23 May (5) (2002) 882-888
91. Sokol D.K., Dunn D.W., Edwards-Brown M., and Feinberg J. Hydrogen proton magnetic resonance spectroscopy in autism: preliminary evidence of elevated choline/creatine ratio. J Child Neurol 17 April (4) (2002) 245-249
92. Murphy D.G., Critchley H.D., Schmitz N., et al. Asperger syndrome: a proton magnetic resonance spectroscopy study of brain. Arch Gen Psychiatry 59 October (10) (2002) 885-891
93. MacMaster F.P., Carrey N., Sparkes S., and Kusumakar V. Proton spectroscopy in medication-free pediatric attention-deficit/hyperactivity disorder. Biol Psychiatry 53 January (2) (2003) 184-187
94. Courvoisie H., Hooper S.R., Fine C., Kwock L., and Castillo M. Neurometabolic functioning and neuropsychological correlates in children with ADHD-H: preliminary findings. J Neuropsychiatry Clin Neurosci 16 Winter (1) (2004) 63-69
95. Ross B.D., Ernst T., Kreis R., et al. 1H MRS in acute traumatic brain injury. J Magn Reson Imaging 8 July-August (4) (1998) 829-840
96. Ashwal S., Holshouser B., Tong K., et al. Proton MR spectroscopy detected glutamate/glutamine is increased in children with traumatic brain injury. J Neurotrauma 21 November (11) (2004) 1539-1552
97. Chang L., Smith L.M., LoPresti C., et al. Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Res 132 December (2) (2004) 95-106
98. Toro R., Leonard G., Lerner J.V., et al. Prenatal exposure to maternal cigarette smoking and the adolescent cerebral cortex. Neuropsychopharmacology 33 April (5) (2008) 1019-1027
99. Spadoni A.D., McGee C.L., Fryer S.L., and Riley E.P. Neuroimaging and fetal alcohol spectrum disorders. Neurosci Biobehav Rev 31 2 (2007) 239-245
100. Peterson B.S. Conceptual, methodological, and statistical challenges in brain imaging studies of developmentally based psychopathologies. Dev Psychopathol 15 Summer (3) (2003) 811-832
101. Teicher M.H., Anderson C.M., Polcari A., Glod C.A., Maas L.C., and Renshaw P.F. Functional deficits in basal ganglia of children with attention-deficit/hyperactivity disorder shown with functional magnetic resonance imaging relaxometry. Nat Med 6 April (4) (2000) 470-473
102. Castellanos F.X., Giedd J.N., Marsh W.L., et al. Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch Gen Psychiatry 53 July (7) (1996) 607-616
103. Castellanos F.X., Sharp W.S., Gottesman R.F., Greenstein D.K., Giedd J.N., and Rapoport J.L. Anatomic brain abnormalities in monozygotic twins discordant for attention deficit hyperactivity disorder. Am J Psychiatry 160 September (9) (2003) 1693-1696
104. Drug use among women delivering live births, 1992. Vol NIH Publication Number 96-3819: NIDA, Rockville, MD. National Pregnancy and Health Survey,1996.
105. Fried P.A., and Smith A.M. A literature review of the consequences of prenatal marihuana exposure. An emerging theme of a deficiency in aspects of executive function. Neurotoxicol Teratol 23 January-February (1) (2001) 1-11
106. Ameri A. The effects of cannabinoids on the brain. Prog Neurobiol 58 July (4) (1999) 315-348
107. Tanda G., and Goldberg S.R. Cannabinoids: reward, dependence, and underlying neurochemical mechanisms-a review of recent preclinical data. Psychopharmacology (Berl) 169 September (2) (2003) 115-134
108. Mackie K., and Stella N. Cannabinoid receptors and endocannabinoids: evidence for new players. Aaps J 8 2 (2006) E298-E306
109. Harkany T., Guzman M., Galve-Roperh I., Berghuis P., Devi L.A., and Mackie K. The emerging functions of endocannabinoid signaling during CNS development. Trends Pharmacol Sci 28 February (2) (2007) 83-92
110. Glass M., Dragunow M., and Faull R.L. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77 March (2) (1997) 299-318
111. Bernard C., Milh M., Morozov Y.M., Ben-Ari Y., Freund T.F., and Gozlan H. Altering cannabinoid signaling during development disrupts neuronal activity. Proc Natl Acad Sci USA 102 June (26) (2005) 9388-9393
112. Lester B.M., and Dreher M. Effects of marijuana use during pregnancy on newborn cry. Child Dev 60 August (4) (1989) 765-771
113. Scher M.S., Richardson G.A., and Day N.L. Effects of prenatal cocaine/crack and other drug exposure on electroencephalographic sleep studies at birth and one year. Pediatrics 105 January (1 Pt 1) (2000) 39-48
114. Goldschmidt L., Richardson G.A., Willford J., and Day N.L. Prenatal Marijuana Exposure and Intelligence Test Performance at Age 6. J Am Acad Child Adolesc Psychiatry (January 2008)
115. Day N.L., Richardson G.A., Goldschmidt L., et al. Effect of prenatal marijuana exposure on the cognitive development of offspring at age three. Neurotoxicol Teratol 16 March-April (2) (1994) 169-175
116. Fried P.A., and Watkinson B. 36- and 48-month neurobehavioral follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol. J Dev Behav Pediatr 11 April (2) (1990) 49-58
117. Fried P.A., Watkinson B., and Gray R. Growth from birth to early adolescence in offspring prenatally exposed to cigarettes and marijuana. Neurotoxicol Teratol 21 September-October (5) (1999) 513-525
118. Fried P.A., and Watkinson B. Differential effects on facets of attention in adolescents prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol 23 September-October (5) (2001) 421-430
119. Richardson G.A., Ryan C., Willford J., Day N.L., and Goldschmidt L. Prenatal alcohol and marijuana exposure: effects on neuropsychological outcomes at 10 years. Neurotoxicol Teratol 24 May-June (3) (2002) 309-320
120. Goldschmidt L., Day N.L., and Richardson G.A. Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicol Teratol 22 May-June (3) (2000) 325-336
121. Smith A.M., Fried P.A., Hogan M.J., and Cameron I. Effects of prenatal marijuana on visuospatial working memory: an fMRI study in young adults. Neurotoxicol Teratol 28 March-April (2) (2006) 286-295
122. Wilson W., Mathew R., Turkington T., Hawk T., Coleman R.E., and Provenzale J. Brain morphological changes and early marijuana use: a magnetic resonance and positron emission tomography study. J Addict Dis 19 1 (2000) 1-22
123. Quickfall J., and Crockford D. Brain neuroimaging in cannabis use: a review. J Neuropsychiatry Clin Neurosci 18 Summer (3) (2006) 318-332
124. Chang L., and Chronicle E.P. Functional imaging studies in cannabis users. Neuroscientist 13 October (5) (2007) 422-432
125. Smith A.M., Fried P.A., Hogan M.J., and Cameron I. Effects of prenatal marijuana on response inhibition: an fMRI study of young adults. Neurotoxicol Teratol 26 July-August (4) (2004) 533-542
126. Jones K.L., and Smith D.W. Recognition of the fetal alcohol syndrome in early infancy. Lancet 2 November (7836) (1973) 999-1001
127. May P.A., and Gossage J.P. Estimating the prevalence of fetal alcohol syndrome. A summary. Alcohol Res Health 25 3 (2001) 159-167
128. Bauer-Moffett C., and Altman J. The effect of ethanol chronically administered to preweanling rats on cerebellar development: a morphological study. Brain Res 119 January (2) (1977) 249-268
129. Bonthius D.J., and West J.R. Alcohol-induced neuronal loss in developing rats: increased brain damage with binge exposure. Alcohol Clin Exp Res 14 February (1) (1990) 107-118
130. Miller M.W., and Robertson S. Prenatal exposure to ethanol alters the postnatal development and transformation of radial glia to astrocytes in the cortex. J Comp Neurol 337 2 (1993) 253-266
131. Gressens P., Lammens M., Picard J.J., and Evrard P. Ethanol-induced disturbances of gliogenesis and neuronogenesis in the developing murine brain: an in vitro and in vivo immunohistochemical and ultrastructural study. Alcohol Alcohol 27 3 (1992) 219-226
132. Olney J.W., Ishimaru M.J., Bittigau P., and Ikonomidou C. Ethanol-induced apoptotic neurodegeneration in the developing brain. Apoptosis 5 December (6) (2000) 515-521
133. Shankar K., Ronis M.J., and Badger T.M. Effects of pregnancy and nutritional status on alcohol metabolism. Alcohol Res Health 30 1 (2007) 55-59
134. May P.A., Gossage J.P., Marais A.S., et al. Maternal risk factors for fetal alcohol syndrome and partial fetal alcohol syndrome in South Africa: a third study. Alcohol Clin Exp Res 32 May (5) (2008) 738-753
135. Warren K.R., and Li T.K. Genetic polymorphisms: impact on the risk of fetal alcohol spectrum disorders. Birth Defects Res A Clin Mol Teratol 73 April (4) (2005) 195-203
136. Mitchell J.J., Paiva M., Moore D.B., Walker D.W., and Heaton M.B. A comparative study of ethanol, hypoglycemia, hypoxia and neurotrophic factor interactions with fetal rat hippocampal neurons: a multi-factor in vitro model developmental ethanol effects. Brain Res Dev Brain Res 105 February (2) (1998) 241-250
137. Colton C.A., Snell-Callanan J., and Chernyshev O.N. Ethanol induced changes in superoxide anion and nitric oxide in cultured microglia. Alcohol Clin Exp Res 22 May (3) (1998) 710-716
138. Bearer C.F. L1 cell adhesion molecule signal cascades: targets for ethanol developmental neurotoxicity. Neurotoxicology 22 October (5) (2001) 625-633
139. Guerri C. Neuroanatomical and neurophysiological mechanisms involved in central nervous system dysfunctions induced by prenatal alcohol exposure. Alcohol Clin Exp Res 22 April (2) (1998) 304-312
140. Archibald S.L., Fennema-Notestine C., Gamst A., Riley E.P., Mattson S.N., and Jernigan T.L. Brain dysmorphology in individuals with severe prenatal alcohol exposure. Dev Med Child Neurol 43 March (3) (2001) 148-154
141. Autti-Ramo I., Autti T., Korkman M., Kettunen S., Salonen O., and Valanne L. MRI findings in children with school problems who had been exposed prenatally to alcohol. Dev Med Child Neurol 44 February (2) (2002) 98-106
142. Sowell E.R., Thompson P.M., Mattson S.N., et al. Voxel-based morphometric analyses of the brain in children and adolescents prenatally exposed to alcohol. Neuroreport 12 March (3) (2001) 515-523
143. Sowell E.R., Thompson P.M., Mattson S.N., et al. Regional brain shape abnormalities persist into adolescence after heavy prenatal alcohol exposure. Cereb Cortex 12 August (8) (2002) 856-865
144. Sowell E.R., Mattson S.N., Thompson P.M., Jernigan T.L., Riley E.P., and Toga A.W. Mapping callosal morphology and cognitive correlates: effects of heavy prenatal alcohol exposure. Neurology 57 July (2) (2001) 235-244
145. Sowell E.R., Thompson P.M., Peterson B.S., et al. Mapping cortical gray matter asymmetry patterns in adolescents with heavy prenatal alcohol exposure. Neuroimage 17 December (4) (2002) 1807-1819
146. Kodituwakku P.W., Kalberg W., and May P.A. The effects of prenatal alcohol exposure on executive functioning. Alcohol Res Health 25 3 (2001) 192-198
147. Sowell E.R., Mattson S.N., Kan E., Thompson P.M., Riley E.P., and Toga A.W. Abnormal cortical thickness and brain-behavior correlation patterns in individuals with heavy prenatal alcohol exposure. Cereb Cortex 18 January (1) (2008) 136-144
148. Narr K.L., Bilder R.M., Toga A.W., et al. Mapping cortical thickness and gray matter concentration in first episode schizophrenia. Cereb Cortex 15 June (6) (2005) 708-719
149. Shaw P., Greenstein D., Lerch J., et al. Intellectual ability and cortical development in children and adolescents. Nature 440 March (7084) (2006) 676-679
150. Swayze II V.W., Johnson V.P., Hanson J.W., et al. Magnetic resonance imaging of brain anomalies in fetal alcohol syndrome. Pediatrics 99 February (2) (1997) 232-240
151. Riley E.P., Mattson S.N., Sowell E.R., Jernigan T.L., Sobel D.F., and Jones K.L. Abnormalities of the corpus callosum in children prenatally exposed to alcohol. Alcohol Clin Exp Res 19 October (5) (1995) 1198-1202
152. Bookstein F.L., Sampson P.D., Streissguth A.P., and Connor P.D. Geometric morphometrics of corpus callosum and subcortical structures in the fetal-alcohol-affected brain. Teratology 64 July (1) (2001) 4-32
153. Bookstein F.L., Streissguth A.P., Sampson P.D., Connor P.D., and Barr H.M. Corpus callosum shape and neuropsychological deficits in adult males with heavy fetal alcohol exposure. Neuroimage 15 January (1) (2002) 233-251
154. Ma X., Coles C.D., Lynch M.E., et al. Evaluation of corpus callosum anisotropy in young adults with fetal alcohol syndrome according to diffusion tensor imaging. Alcohol Clin Exp Res 29 July (7) (2005) 1214-1222
155. Wozniak J.R., Mueller B.A., Chang P.N., Muetzel R.L., Caros L., and Lim K.O. Diffusion tensor imaging in children with fetal alcohol spectrum disorders. Alcohol Clin Exp Res 30 October (10) (2006) 1799-1806
156. Sowell E.R., Johnson A., Kan E., et al. Mapping white matter integrity and neurobehavioral correlates in children with fetal alcohol spectrum disorders. J Neurosci 28 February (6) (2008) 1313-1319
157. Roebuck T.M., Mattson S.N., and Riley E.P. Interhemispheric transfer in children with heavy prenatal alcohol exposure. Alcohol Clin Exp Res 26 December (12) (2002) 1863-1871
158. Kim J.J., and Thompson R.F. Cerebellar circuits and synaptic mechanisms involved in classical eyeblink conditioning. Trends Neurosci 20 April (4) (1997) 177-181
159. Sowell E.R., Jernigan T.L., Mattson S.N., Riley E.P., Sobel D.F., and Jones K.L. Abnormal development of the cerebellar vermis in children prenatally exposed to alcohol: size reduction in lobules I-V. Alcohol Clin Exp Res 20 February (1) (1996) 31-34
160. O'Hare E.D., Kan E., Yoshii J., et al. Mapping cerebellar vermal morphology and cognitive correlates in prenatal alcohol exposure. Neuroreport 16 August (12) (2005) 1285-1290
161. Riikonen R., Salonen I., Partanen K., and Verho S. Brain perfusion SPECT and MRI in foetal alcohol syndrome. Dev Med Child Neurol 41 October (10) (1999) 652-659
162. Mattson S.N., Riley E.P., Jernigan T.L., et al. A decrease in the size of the basal ganglia following prenatal alcohol exposure: a preliminary report. Neurotoxicol Teratol 16 May-June (3) (1994) 283-289
163. Mattson S.N., Riley E.P., Sowell E.R., Jernigan T.L., Sobel D.F., and Jones K.L. A decrease in the size of the basal ganglia in children with fetal alcohol syndrome. Alcohol Clin Exp Res 20 September (6) (1996) 1088-1093
164. Clark C.M., Li D., Conry J., Conry R., and Loock C. Structural and functional brain integrity of fetal alcohol syndrome in nonretarded cases. Pediatrics 105 May (5) (2000) 1096-1099
165. Cortese B.M., Moore G.J., Bailey B.A., Jacobson S.W., Delaney-Black V., and Hannigan J.H. Magnetic resonance and spectroscopic imaging in prenatal alcohol-exposed children: preliminary findings in the caudate nucleus. Neurotoxicol Teratol 28 September-October (5) (2006) 597-606
166. Ebrahim S.H., Floyd R.L., Merritt II R.K., Decoufle P., and Holtzman D. Trends in pregnancy-related smoking rates in the United States, 1987-1996. JAMA 283 January (3) (2000) 361-366
167. Martin J.A., Hamilton B.E., Ventura S.J., Menacker F., Park M.M., and Sutton P.D. Births: final data for 2001. Natl Vital Stat Rep 51 December (2) (2002) 1-102
168. Martin J.A., Kochanek K.D., Strobino D.M., Guyer B., and MacDorman M.F. Annual summary of vital statistics--2003. Pediatrics 115 March (3) (2005) 619-634
169. Ernst M., Moolchan E.T., and Robinson M.L. Behavioral and neural consequences of prenatal exposure to nicotine. J Am Acad Child Adolesc Psychiatry 40 June (6) (2001) 630-641
170. Slotkin T.A., Seidler F.J., Qiao D., et al. Effects of prenatal nicotine exposure on primate brain development and attempted amelioration with supplemental choline or vitamin C: neurotransmitter receptors, cell signaling and cell development biomarkers in fetal brain regions of rhesus monkeys. Neuropsychopharmacology 30 January (1) (2005) 129-144
171. Schneider A.S., Atluri P., Shen Q., et al. Functional nicotinic acetylcholine receptor expression on stem and progenitor cells of the early embryonic nervous system. Ann N Y Acad Sci 971 October (2002) 135-138
172. Slotkin T.A. Cholinergic systems in brain development and disruption by neurotoxicants: nicotine, environmental tobacco smoke, organophosphates. Toxicol Appl Pharmacol 198 July (2) (2004) 132-151
173. Muneoka K., Nakatsu T., Fuji J., Ogawa T., and Takigawa M. Prenatal administration of nicotine results in dopaminergic alterations in the neocortex. Neurotoxicol Teratol 21 September-October (5) (1999) 603-609
174. Muneoka K., Ogawa T., Kamei K., et al. Prenatal nicotine exposure affects the development of the central serotonergic system as well as the dopaminergic system in rat offspring: involvement of route of drug administrations. Brain Res Dev Brain Res 102 August (1) (1997) 117-126
175. Richardson S.A., and Tizabi Y. Hyperactivity in the offspring of nicotine-treated rats: role of the mesolimbic and nigrostriatal dopaminergic pathways. Pharmacol Biochem Behav 47 February (2) (1994) 331-337
176. Xu Z., Seidler F.J., Ali S.F., Slikker Jr. W., and Slotkin T.A. Fetal and adolescent nicotine administration: effects on CNS serotonergic systems. Brain Res 914 September (1-2) (2001) 166-178
177. Ernst M., Matochik J.A., Heishman S.J., et al. Effect of nicotine on brain activation during performance of a working memory task. Proc Natl Acad Sci USA 98 April (8) (2001) 4728-4733
178. Shea A.K., and Steiner M. Cigarette smoking during pregnancy. Nicotine Tob Res 10 February (2) (2008) 267-278
179. Kallen K. Maternal smoking during pregnancy and infant head circumference at birth. Early Hum Dev 58 June (3) (2000) 197-204
180. Shankaran S., Das A., Bauer C.R., et al. Association between patterns of maternal substance use and infant birth weight, length, and head circumference. Pediatrics 114 August (2) (2004) e226-e234
181. Weissman M.M., Warner V., Wickramaratne P.J., and Kandel D.B. Maternal smoking during pregnancy and psychopathology in offspring followed to adulthood. J Am Acad Child Adolesc Psychiatry 38 July (7) (1999) 892-899
182. Breslau N., and Chilcoat H.D. Psychiatric sequelae of low birth weight at 11 years of age. Biol Psychiatry 47 June (11) (2000) 1005-1011
183. Milberger S., Biederman J., Faraone S.V., and Jones J. Further evidence of an association between maternal smoking during pregnancy and attention deficit hyperactivity disorder: findings from a high-risk sample of siblings. J Clin Child Psychol 27 October (3) (1998) 352-358
184. D'Onofrio B.M., Van Hulle C.A., Waldman I.D., et al. Smoking during pregnancy and offspring externalizing problems: an exploration of genetic and environmental confounds. Dev Psychopathol 20 Winter (1) (2008) 139-164
185. Jacobsen L.K., Slotkin T.A., Westerveld M., Mencl W.E., and Pugh K.R. Visuospatial memory deficits emerging during nicotine withdrawal in adolescents with prenatal exposure to active maternal smoking. Neuropsychopharmacology 31 July (7) (2006) 1550-1561
186. Fried P.A. Prenatal exposure to marihuana and tobacco during infancy, early and middle childhood: effects and an attempt at synthesis. Arch Toxicol Suppl 17 (1995) 233-260
187. Obel C., Henriksen T.B., Hedegaard M., Secher N.J., and Ostergaard J. Smoking during pregnancy and babbling abilities of the 8-month-old infant. Paediatr Perinat Epidemiol 12 January (1) (1998) 37-48
188. Jacobsen L.K., Slotkin T.A., Mencl W.E., Frost S.J., and Pugh K.R. Gender-specific effects of prenatal and adolescent exposure to tobacco smoke on auditory and visual attention. Neuropsychopharmacology 32 December (12) (2007) 2453-2464
189. Slikker Jr. W., Xu Z.A., Levin E.D., and Slotkin T.A. Mode of action: disruption of brain cell replication, second messenger, and neurotransmitter systems during development leading to cognitive dysfunction--developmental neurotoxicity of nicotine. Crit Rev Toxicol 35 October-November (8-9) (2005) 703-711
190. Paus T., Nawazkhan I., Leonard G., et al. Corpus callosum in adolescent offspring exposed prenatally to maternal cigarette smoking. Neuroimage 40 April (2) (2008) 435-441
191. Hofer S., and Frahm J. Topography of the human corpus callosum revisited--comprehensive fiber tractography using diffusion tensor magnetic resonance imaging. Neuroimage 32 September (3) (2006) 989-994
192. Herlenius E., and Lagercrantz H. Neurotransmitters and neuromodulators during early human development. Early Hum Dev 65 October (1) (2001) 21-37
193. Seguin J.R. Neurocognitive elements of antisocial behavior: Relevance of an orbitofrontal cortex account. Brain Cogn 55 June (1) (2004) 185-197
194. Jacobsen L.K., Picciotto M.R., Heath C.J., et al. Prenatal and adolescent exposure to tobacco smoke modulates the development of white matter microstructure. J Neurosci 27 December (49) (2007) 13491-13498
195. Beaulieu C. The basis of anisotropic water diffusion in the nervous system - a technical review. NMR Biomed 15 November-December (7-8) (2002) 435-455
196. Barnea-Goraly N., Menon V., Eckert M., et al. White matter development during childhood and adolescence: a cross-sectional diffusion tensor imaging study. Cereb Cortex 15 December (12) (2005) 1848-1854
197. Mabbott D.J., Noseworthy M., Bouffet E., Laughlin S., and Rockel C. White matter growth as a mechanism of cognitive development in children. Neuroimage 33 November (3) (2006) 936-946
198. Sarter M., Hasselmo M.E., Bruno J.P., and Givens B. Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection. Brain Res Brain Res Rev 48 February (1) (2005) 98-111
199. Furey M.L., Pietrini P., and Haxby J.V. Cholinergic enhancement and increased selectivity of perceptual processing during working memory. Science 290 December (5500) (2000) 2315-2319
200. McClelland J.L., and Goddard N.H. Considerations arising from a complementary learning systems perspective on hippocampus and neocortex. Hippocampus 6 6 (1996) 654-665
201. Abreu-Villaca Y., Seidler F.J., and Slotkin T.A. Does prenatal nicotine exposure sensitize the brain to nicotine-induced neurotoxicity in adolescence?. Neuropsychopharmacology 29 August (8) (2004) 1440-1450
202. Walhovd K.B., Moe V., Slinning K., Due-Tonnessen P., Bjornerud A., Dale A.M., van der Kouwe A., Quinn B.T., Kosofsky B., Greve D., and Fischl B. Volumetric cerebral characteristics of children exposed to opiates and other substances in utero. Neuroimage 36 4 (2007) 1331-1344
203. Lester BM, Lagasse, LL. Children of Addicted Women, in Women, Children and Addiction, Supplement to the Journal of Addictive Diseases, in press.